Introduction: Anterior communicating artery aneurysms (ACoAAs) are the most frequent intracranial aneurysms treated at neurosurgical departments with a vascular program. Material and methods: We reviewed patients with ACoAAs in a single institution over ten years (2008–2017). The focus was on the final outcome; complications, age, and clinical condition with respect to modalities were analyzed. Results: A total of 198 patients treated during this period was included in the study: 176 patients had a ruptured ACoAA and 22 had an unruptured ACoAA. Then, 127 (71%) were treated surgically and 51 (29%) by endovascular means. Out of the whole series, a good recovery occurred in 123 patients (62%), moderate disability in 11 (5.5%), severe disability in 19 (10%), vegetative state in 11 (5.5%), and death in 34 (17%). In the 157 patients (72.5%) with a subarachnoid hemorrhage (SAH), both modalities had a favorable outcome: 27.5% had an unfavorable outcome, 12% had complications in surgery versus 17.6% during endovascular treatment. No statistical difference in outcome, complications, and age was noted between modalities. Surgical treatment was more frequently adopted for patients in a better clinical condition (p ≤ 0.05). Conclusion: More than two thirds of the patients (72.5%) reached a favorable outcome. There was no difference in age between the treatment modalities. Risks of complications are present and specific for both modalities.

中文翻译：

---

目前前交通动脉瘤的治疗：单中心研究。

简介：前交通动脉瘤 (ACoAA) 是神经外科血管治疗中最常见的颅内动脉瘤。材料和方法：我们回顾了一个机构十年（2008-2017）的 ACoAA 患者。焦点在于最终的结果；分析了并发症、年龄和与治疗方式有关的临床状况。结果：该研究共纳入了这一时期接受治疗的 198 名患者：176 名患者 ACoAA 破裂，22 名患者 ACoAA 未破裂。然后，127 例（71%）接受了手术治疗，51 例（29%）接受了血管内治疗。整个系列中，123例患者（62%）康复良好，11例（5.5%）中度残疾，19例（10%）重度残疾，11例（5.5%）植物人状态，34例死亡（ 17%）。在 157 名蛛网膜下腔出血 (SAH) 患者 (72.5%) 中，两种治疗方式均取得了良好的结果：27.5% 的患者结果不佳，12% 的患者在手术中出现并发症，而 17.6% 的患者在血管内治疗期间出现并发症。不同治疗方式之间的结果、并发症和年龄没有统计学差异。临床状况较好的患者更常采用手术治疗（p≤0.05）。结论：超过三分之二的患者（72.5%）达到了良好的结果。治疗方式之间的年龄没有差异。两种治疗方式均存在且特定的并发症风险。